N.Y. Wants Drug-Pricing Data From AWP Defendants

Law360, New York (February 1, 2008, 12:00 AM EST) -- The State of New York on Thursday asked a federal court to compel Abbot Laboratories and other defendants to produce sale and transactional data used to determine pricing for certain drugs in the ongoing litigation over inflated average wholesale pricing in the pharmaceutical industry.

Abbott is just one of scores of drug makers accused of inflating the reported average wholesale prices of its drugs to defraud Medicare and boost sales.

New York and other plaintiffs said that a previous case management order set forth specific procedures...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.